EUVIMEDEUVIMED entdecken
Crossref

A novel, dominant disease mechanism of distal renal tubular acidosis with specific variants in ATP6V1B1

Myrte Daenen, Marguerite Hureaux, Emma Ashton, Francesca Becherucci iD, Ian Berry, Marcus Benz, Anna Bjerre, Andrew Buckton, Richard Caswell, Celia Duff-Farrier, Samantha Hayward, Joseph Mcallister und 10 weitere

Nephrology Dialysis Transplantation · 2025

DOI: 10.1093/ndt/gfaf016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nephrology Dialysis Transplantation, 2025. Verfasst von Myrte Daenen und 21 weiteren Autor:innen. Beteiligte Einrichtung: Paediatric Nephrology, UZ Leuven and Department of Cellular and Molecular Physiology, KUL, Leuven, Belgium. Hauptthemen laut MEDLINE: Acidosis, Renal Tubular, Vacuolar Proton-Translocating ATPases, Mutation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 16 Literaturangaben. Gefördert von: ERKNet, European Society for Paediatric Nephrology, European Renal Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

ATP6V1B1 encodes a subunit of the vacuolar H+-ATPase and pathogenic variants are associated with autosomal recessive distal renal tubular acidosis (dRTA) with deafness. Heterozygous variants predicted to affect a specific amino acid, Arg394, have been recurrently reported in dRTA but their significance has been unclear. We hypothesized that these variants are associated with a dominant disease mechanism.

Methods

We conducted a retrospective analysis of cases identified in our genetic laboratories and through European nephrology organizations. Data regarding demographics, clinical presentation, laboratory findings, hearing and imaging studies of kidneys were collected from the index patient and, if available, from other family members. The potential disease mechanism was investigated through structural modelling in silico.

Results

Twenty index patients in total were included, of which 19 carried the variant c.1181G>A; p.(Arg394Gln) and one c.1180C>G; p.(Arg394Gly). In seven families, more than one member was affected and the variant segregated with the disease in those with available information (15 affected, 6 unaffected), except for the unaffected mother of 2 affected children, who was mosaic. In no patient was a second causative variant in trans identified. In eight sporadic patients and one affected parent, the variant was confirmed to be de novo. Both variants are absent in gnomAD. Sensorineural hearing loss was reported in 8 of the 22 patients with available information. Structural modelling supports a crucial role for Arg394 in nucleotide binding.

Conclusion

We provide strong evidence for the pathogenicity of heterozygous variants affecting Arg394 and thus a novel inheritance modus for ATP6V1B1-associated dRTA. Clinically, this form differs from the recessive one by the lower prevalence of hearing loss. The prominent position of Arg394 in the nucleotide binding fold of the H+-ATPase structure is consistent with a dominant negative mechanism. Our findings inform the diagnosis and management of patients with dRTA and variants of Arg394.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acidosis, Renal TubularVacuolar Proton-Translocating ATPasesMutationHumansFemaleMaleRetrospective StudiesChildChild, PreschoolAdultAdolescentPedigreePrognosisYoung AdultMiddle AgedInfantFollow-Up Studies

Stichwörter der Autor:innen

ATP6V1B1autosomal dominantdRTAdeafnessdistal renal tubular acidosis

Substanzen

Vacuolar Proton-Translocating ATPasesATP6V1B1 protein, human

Autor:innen und Institutionen

  • Paediatric Nephrology, UZ Leuven and Department of Cellular and Molecular Physiology, KUL, Leuven, Belgium.
  • Assistance Publique - Hôpitaux de Paris, Genetic Department and Reference Center for Rare Kidney Diseases (MARHEA), Hôpital Européen Georges Pompidou, Paris, France.
  • Université Paris Cité, INSERM U970 Paris Cardiovascular Research Center, Paris, France.
  • Rare and Inherited Disease Laboratory, NHS North Thames Genomic Laboratory Hub, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
  • Nephrology and Dialysis Unit, Meyer Children's Hospital IRCCS, Florence, Italy.
  • Department of Biomedical, Experimental and Clinical Sciences "Mario Serio", University of Florence, Florence, Italy.

ORCID-Profile: Francesca Becherucci, Francesco Emma, Detlef Bockenhauer

Förderung

  • ERKNet
  • European Society for Paediatric Nephrology
  • European Renal Association

Zitieren

APA

Daenen, M., Hureaux, M., Ashton, E., Becherucci, F., Berry, I., Benz, M., Bjerre, A., Buckton, A., Caswell, R., Duff-Farrier, C., Hayward, S., Mcallister, J., Moczulska, A., Palazzo, V., Platt, C., Prajapati, H., Saleem, M. A., Schlingmann, K. P., Francisco, T., …, & Bockenhauer, D. (2025). A novel, dominant disease mechanism of distal renal tubular acidosis with specific variants in ATP6V1B1. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfaf016

Vancouver

Daenen M, Hureaux M, Ashton E, Becherucci F, Berry I, Benz M, et al. A novel, dominant disease mechanism of distal renal tubular acidosis with specific variants in ATP6V1B1. Nephrology Dialysis Transplantation. 2025. doi:10.1093/ndt/gfaf016

BibTeX
@article{Daenen2025,
  author = {Daenen, Myrte and Hureaux, Marguerite and Ashton, Emma and Becherucci, Francesca and Berry, Ian and Benz, Marcus and Bjerre, Anna and Buckton, Andrew and Caswell, Richard and Duff-Farrier, Celia and Hayward, Samantha and Mcallister, Joseph and Moczulska, Anna and Palazzo, Viviana and Platt, Caroline and Prajapati, Hitesh and Saleem, Moin A and Schlingmann, Karl-Peter and Francisco, Telma and Zaniew, Marcin and Emma, Francesco and Bockenhauer, Detlef},
  title = {A novel, dominant disease mechanism of distal renal tubular acidosis with specific variants in ATP6V1B1},
  journal = {Nephrology Dialysis Transplantation},
  year = {2025},
  doi = {10.1093/ndt/gfaf016}
}
Kostenlos starten →